Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Ambroxol Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 60Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    The APIs in Ambroxol HCL API Powder is produced by Cerata Pharma.
    The APIs in Ambroxol HCL API Powder is produced by Cerata Pharma.

    01 Oct 2024

    // PRESS RELEASE

    https://ceratapharma.com/news-detail/The-Active-Pharmaceutical-Ingredient-API

    PRESS RELEASE
    01 Oct 2024
    Share Share
    Ambroxol HCl API: Mucolytic agent that helps thin mucus
    Ambroxol HCl API: Mucolytic agent that helps thin mucus

    18 May 2024

    // PRESS RELEASE

    https://ceratapharma.com/news-detail/Ambroxol-HCl-API-Mucolytic-agent-that-he

    PRESS RELEASE
    18 May 2024
    Share Share
    Sanofi grabs non-prescription rights to Roche's Tamiflu
    Sanofi grabs non-prescription rights to Roche's Tamiflu

    23 Jul 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/xofluza-hand-roche-offloads-tamiflu-u-s-otc-switch-rights-to-sanofi

    Angus Liu FIERCE PHARMA
    23 Jul 2019
    Share Share
    Kores (India) Ltd. Fails EDQM Inspection
    Kores (India) Ltd. Fails EDQM Inspection

    20 Dec 2018

    // EDQM

    https://www.pharmacompass.com/pdf/news/kores-india-ltd-fails-edqm-inspection-1545309683.pdf

    EDQM
    20 Dec 2018
    Share Share
    Italian regulators find problems at Kores' API plant in Roha
    Italian regulators find problems at Kores' API plant in Roha

    11 May 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Italian-regulators-find-problems-at-Kores-Limited-API-plant-in-Roha

    G. MacDonald IN PHARMATECHNOLOGIST
    11 May 2017
    Share Share
    Mexico raises cough medicine objection to Sanofi-Boehringer deal
    Mexico raises cough medicine objection to Sanofi-Boehringer deal

    19 Dec 2016

    // Michael O\'Boyle REUTERS

    http://uk.reuters.com/article/mexico-sanofi-idUKL1N1EE0YZ?rpc=401&

    Michael O\'Boyle REUTERS
    19 Dec 2016
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.